Faeth Therapeutics , a clinical-stage biotechnology company targeting cancer metabolism, today announced the appointment of Debbie Chirnomas M.D., M.P.H., as Chief Medical Officer. Dr. Chirnomas will head up the early and late-stage clinical development for Faeth's oncology pipeline.

Everything needs food to survive and grow, including cancer. There is an entire dimension of human biology in metabolism that’s been too complex to leverage in the fight against cancer––until now. 



Faeth Therapeutics Appoints Debbie Chirnomas, M.D., M.P.H., As Chief Medical Officer Benzinga

Faeth Therapeutics Appoints Debbie Chirnomas, M.D., M.P.H., As Chief Medical Officer Benzinga

Company Info

Related People